Scholarlink

Background <p>Real-world evidence regarding surgery for clinical T4 (cT4) nonsmall cell lung cancer (NSCLC) is limited. We evaluated outcomes and prognostic factors of cT4 NSCLC using the 9th edition TNM classification.</p> Patients and Methods <p>This multi-institutional retrospective study included patients who underwent pulmonary resection for cT4N0-2bM0 NSCLC between 2010 and 2019. Prognostic factors for relapse-free survival (RFS) and overall survival (OS) were analyzed in patients who achieved R0 resection. OS was compared across cT4 subgroups and cN categories.</p> Results <p>Among 165 patients, 71 were classified as cT4 owing to invasion of neighboring organs. Clinical nodal status was cN0 in 97, cN1 in 40, cN2a in 21, and cN2b in 7. Preoperative therapy was administered in 44 patients. Postoperative complications occurred in 48%, with 90-day mortality of 2.4%. OS after R0 resection was significantly longer than after R1-2 resection. The 5-year RFS and OS of 149 R0-resected patients were 43 and 61%, respectively. The 5-year RFS rates were 47% for pN0-1, 28% for pN2a, and 17% for pN2b; corresponding OS rates were 63, 48, and 50%, respectively. Multivariable analysis identified pN status and preoperative therapy as independent predictors of RFS, and pN status was an independent predictor of OS. OS did not differ among cT4 subgroups (size alone, invasion alone, or both). Prognosis was similar between cT4cN0-1 and cT4cN2a, whereas cT4cN2b had significantly worse outcomes.</p> Conclusions <p>Surgery for cT4 NSCLC can achieve favorable results when R0 resection is feasible. Tumors with dual T4 factors and selected cT4N2a disease may benefit from surgery-inclusive treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Long-term Outcomes of Surgery for Clinical T4 Non-Small Cell Lung Cancer: Implications for Surgical Decision Making in the TNM 9th Edition Era

  • 期刊论文

  • 发表日期：

    2026年6月29日

查看全文
  • Ryu Kanzaki,
  • Jiro Okami,
  • Toshiteru Tokunaga,
  • Teruo Iwasaki,
  • Makoto Takahama,
  • Yasushi Sakamaki,
  • Masahiko Higashiyama,
  • Naoki Ikeda,
  • Koji Takami,
  • Hideoki Yokouchi,
  • Yukiyasu Takeuchi,
  • Toru Momozane,
  • Yoshihisa Kadota,
  • Makoto Fujii,
  • Yasushi Shintani

摘要

Background

Real-world evidence regarding surgery for clinical T4 (cT4) nonsmall cell lung cancer (NSCLC) is limited. We evaluated outcomes and prognostic factors of cT4 NSCLC using the 9th edition TNM classification.

Patients and Methods

This multi-institutional retrospective study included patients who underwent pulmonary resection for cT4N0-2bM0 NSCLC between 2010 and 2019. Prognostic factors for relapse-free survival (RFS) and overall survival (OS) were analyzed in patients who achieved R0 resection. OS was compared across cT4 subgroups and cN categories.

Results

Among 165 patients, 71 were classified as cT4 owing to invasion of neighboring organs. Clinical nodal status was cN0 in 97, cN1 in 40, cN2a in 21, and cN2b in 7. Preoperative therapy was administered in 44 patients. Postoperative complications occurred in 48%, with 90-day mortality of 2.4%. OS after R0 resection was significantly longer than after R1-2 resection. The 5-year RFS and OS of 149 R0-resected patients were 43 and 61%, respectively. The 5-year RFS rates were 47% for pN0-1, 28% for pN2a, and 17% for pN2b; corresponding OS rates were 63, 48, and 50%, respectively. Multivariable analysis identified pN status and preoperative therapy as independent predictors of RFS, and pN status was an independent predictor of OS. OS did not differ among cT4 subgroups (size alone, invasion alone, or both). Prognosis was similar between cT4cN0-1 and cT4cN2a, whereas cT4cN2b had significantly worse outcomes.

Conclusions

Surgery for cT4 NSCLC can achieve favorable results when R0 resection is feasible. Tumors with dual T4 factors and selected cT4N2a disease may benefit from surgery-inclusive treatment.